Naxicap Partners becomes the majority shareholder of Lagarrigue Group
Naxicap Partners has acquired a majority stake in Lagarrigue Group.
As one of the top private equity firms in France, Naxicap Partners – an affiliate of Natixis Investment Managers – has US$4.8 billion in assets under management. As a committed, responsible investor, Naxicap Partners builds solid, constructive partnerships with entrepreneurs so that their projects can succeed. The firm has 39 investment professionals spread across five offices in Paris, Lyon, Toulouse and Nantes in France, and Frankfurt in Germany.
Lagarrigue Group is a global specialist in external orthopedic devices (prostheses/orthoses) and in the design and manufacture of custom-made large orthopedic devices (LAD) for the treatment of disabilities. Lagarrigue is an international player, thanks to a very active external growth strategy that has led to nearly 25 acquisitions since 2016.
Ardian is one of the world’s leading private equity firms with US$110 billion under management and/or advisory in Europe, America and Asia. The firm, majority-owned by its employees, places entrepreneurship at the heart of its approach and offers its international investors top-tier performance.
Oaklins’ team in France acted as advisor to Naxicap Partners in this transaction.
Talk to the deal team
Related deals
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreGroupe JVS has completed an LBO with Capza and Bpifrance
The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more